{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:55Z","timestamp":1792784995944,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FinnGen"},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK43351"],"award-info":[{"award-number":["DK43351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK135492"],"award-info":[{"award-number":["DK135492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK43351"],"award-info":[{"award-number":["DK43351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK135492"],"award-info":[{"award-number":["DK135492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aging Biology Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The high prevalence (&gt;5%) of autoimmune hypothyroidism (AIHT) provides a unique opportunity to dissect genetic contributions to systemic and organ-specific autoimmunity. Here we performed a genome-wide association meta-analysis of 81,718 AIHT cases in FinnGen and the UK Biobank, identifying 418 independent signals (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20095\u2009\u00d7\u200910\n                    <jats:sup>\u22128<\/jats:sup>\n                    ). At 48 of these loci, a protein-coding variant is, or is highly correlated (\n                    <jats:italic>r<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009&gt;\u20090.95) with, the lead variant, including Finnish-enriched coding variants in\n                    <jats:italic>LAG3<\/jats:italic>\n                    ,\n                    <jats:italic>ZAP70<\/jats:italic>\n                    and\n                    <jats:italic>TG<\/jats:italic>\n                    . We demonstrated that\n                    <jats:italic>ZAP70<\/jats:italic>\n                    :T155M reduces T cell activation and broadly compare large-scale scans of nonthyroid autoimmunity and thyroid-stimulating hormone levels with a Bayesian classifier to assign loci into distinct groupings, estimating that 38% are involved in general autoimmunity whereas 20% are thyroid specific. We further identified substantial antagonistic pleiotropy, with 10% of AIHT loci showing a consistent protective effect against skin cancer. The AIHT results, including numerous genes encoding checkpoint proteins, support the causal role of natural immune variation influencing cancer outcomes.\n                  <\/jats:p>","DOI":"10.1038\/s41588-026-02521-1","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:03:08Z","timestamp":1772100188000},"page":"550-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genome-wide association analyses of autoimmune hypothyroidism reveal autoimmune and thyroid-specific contributions and an inverse relationship with cancer risk"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-2321","authenticated-orcid":false,"given":"Mary Pat","family":"Reeve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5165-4408","authenticated-orcid":false,"given":"Masahiro","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8403-8115","authenticated-orcid":false,"given":"Daniel B.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Karjalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8422-4967","authenticated-orcid":false,"given":"Shuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-6775","authenticated-orcid":false,"given":"Nikita","family":"Kolosov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-9314","authenticated-orcid":false,"given":"Jarmo","family":"Ritari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2878-4671","authenticated-orcid":false,"given":"Konrad J.","family":"Karczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6306-8227","authenticated-orcid":false,"given":"Tuomo","family":"Kiiskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6238-7549","authenticated-orcid":false,"given":"Zachary","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0554-4667","authenticated-orcid":false,"given":"Juha","family":"Mehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja I.","family":"Kurki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FinnGen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-4734","authenticated-orcid":false,"given":"Jukka","family":"Partanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5282-8764","authenticated-orcid":false,"given":"Mykyta","family":"Artomov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-5874","authenticated-orcid":false,"given":"Aarno","family":"Palotie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-6202","authenticated-orcid":false,"given":"Tiinamaija","family":"Tuomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-1350","authenticated-orcid":false,"given":"Matti","family":"Pirinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-7222","authenticated-orcid":false,"given":"Jukka","family":"Kero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramnik J.","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-8752","authenticated-orcid":false,"given":"Mark J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-1202","authenticated-orcid":false,"given":"Samuli","family":"Ripatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2521_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12325-019-01080-8","volume":"36","author":"L Chiovato","year":"2019","unstructured":"Chiovato, L., Magri, F. & Carl\u00e9, A. Hypothyroidism in context: where we\u2019ve been and where we\u2019re going. Adv. Ther. 36, 47\u201358 (2019).","journal-title":"Adv. Ther."},{"key":"2521_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00228-010-0884-4","volume":"67","author":"LJ Virta","year":"2011","unstructured":"Virta, L. J. & Eskelinen, S. I. Prevalence of hypothyroidism in Finland\u2014a nationwide prescription study. Eur. J. Clin. Pharmacol. 67, 73\u201377 (2011).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"2521_CR3","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad, N. et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 401, 1878\u20131890 (2023).","journal-title":"Lancet"},{"key":"2521_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ejendo\/lvae094","volume":"191","author":"J Figuer\u00eado","year":"2024","unstructured":"Figuer\u00eado, J. et al. Uncovering the shared genetic components of thyroid disorders and reproductive health. Eur. J. Endocrinol. 191, 211\u2013222 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"2521_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-020-2436-0","volume":"584","author":"S Saevarsdottir","year":"2020","unstructured":"Saevarsdottir, S. et al. FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease. Nature 584, 619\u2013623 (2020).","journal-title":"Nature"},{"key":"2521_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2018.11.008","volume":"104","author":"G Kichaev","year":"2019","unstructured":"Kichaev, G. et al. Leveraging polygenic functional enrichment to improve GWAS power. Am. J. Hum. Genet. 104, 65\u201375 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"2521_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104992","volume":"25","author":"S Mathieu","year":"2022","unstructured":"Mathieu, S. et al. Genetic association and Mendelian randomization for hypothyroidism highlight immune molecular mechanisms. iScience 25, 104992 (2022).","journal-title":"iScience"},{"key":"2521_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj1182","volume":"385","author":"A Verma","year":"2024","unstructured":"Verma, A. et al. Diversity and scale: genetic architecture of 2068 traits in the VA Million Veteran Program. Science 385, eadj1182 (2024).","journal-title":"Science"},{"key":"2521_CR9","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.xgen.2022.100192","volume":"2","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. Global Biobank Meta-analysis Initiative: powering genetic discovery across human disease. Cell Genom. 2, 100192 (2022).","journal-title":"Cell Genom."},{"key":"2521_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"2521_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24\u201334 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2521_CR12","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200239","volume":"2","author":"GV Long","year":"2023","unstructured":"Long, G. V. et al. Overall survival and response with nivolumab and relatlimab in advanced melanoma. NEJM Evid. 2, EVIDoa2200239 (2023).","journal-title":"NEJM Evid."},{"key":"2521_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08259-7","volume":"10","author":"SE Jones","year":"2019","unstructured":"Jones, S. E. et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat. Commun. 10, 343 (2019).","journal-title":"Nat. Commun."},{"key":"2521_CR14","first-page":"E1536","volume":"113","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. A PERIOD3 variant causes a circadian phenotype and is associated with a seasonal mood trait. Proc. Natl Acad. Sci. USA 113, E1536\u2013E1544 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2521_CR15","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/0092-8674(94)90368-9","volume":"76","author":"E Arpaia","year":"1994","unstructured":"Arpaia, E., Shahar, M., Dadi, H., Cohen, A. & Roifman, C. M. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 76, 947\u2013958 (1994).","journal-title":"Cell"},{"key":"2521_CR16","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1126\/science.8202712","volume":"264","author":"ME Elder","year":"1994","unstructured":"Elder, M. E. et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264, 1596\u20131599 (1994).","journal-title":"Science"},{"key":"2521_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1126\/science.8202713","volume":"264","author":"AC Chan","year":"1994","unstructured":"Chan, A. C. et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264, 1599\u20131601 (1994).","journal-title":"Science"},{"key":"2521_CR18","doi-asserted-by":"publisher","first-page":"113393","DOI":"10.1016\/j.ejmech.2021.113393","volume":"219","author":"D Rao","year":"2021","unstructured":"Rao, D. et al. Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor. Eur. J. Med. Chem. 219, 113393 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"2521_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/1087057116681407","volume":"22","author":"PR Visperas","year":"2017","unstructured":"Visperas, P. R. et al. Identification of inhibitors of the association of ZAP-70 with the T cell receptor by high-throughput screen. SLAS Discov. 22, 324\u2013331 (2017).","journal-title":"SLAS Discov."},{"key":"2521_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.13058","volume":"307","author":"JF Ashouri","year":"2022","unstructured":"Ashouri, J. F., Lo, W.-L., Nguyen, T. T. T., Shen, L. & Weiss, A. ZAP70, too little, too much can lead to autoimmunity. Immunol. Rev. 307, 145\u2013160 (2022).","journal-title":"Immunol. Rev."},{"key":"2521_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3389\/fimmu.2020.00831","volume":"11","author":"N Sharifinejad","year":"2020","unstructured":"Sharifinejad, N. et al. Clinical, immunological, and genetic features in 49 patients with ZAP-70 deficiency: a systematic review. Front. Immunol. 11, 831 (2020).","journal-title":"Front. Immunol."},{"key":"2521_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265\u2013276 (2015).","journal-title":"Trends Immunol."},{"key":"2521_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s43018-020-0075-x","volume":"1","author":"SA Oh","year":"2020","unstructured":"Oh, S. A. et al. PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nat. Cancer 1, 681\u2013691 (2020).","journal-title":"Nat. Cancer"},{"key":"2521_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/1078-0432.CCR-15-1136","volume":"22","author":"M Freeman-Keller","year":"2016","unstructured":"Freeman-Keller, M. et al. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin. Cancer Res. 22, 886\u2013894 (2016).","journal-title":"Clin. Cancer Res."},{"key":"2521_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamaoncol.2019.5570","volume":"6","author":"AMM Eggermont","year":"2020","unstructured":"Eggermont, A. M. M. et al. Association between immune-related adverse events and recurrence-free survival among patients with stage III melanoma randomized to receive pembrolizumab or placebo: a secondary analysis of a randomized clinical trial. JAMA Oncol. 6, 519\u2013527 (2020).","journal-title":"JAMA Oncol."},{"key":"2521_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/thy.2019.0250","volume":"30","author":"A Kotwal","year":"2020","unstructured":"Kotwal, A., Kottschade, L. & Ryder, M. PD-L1 inhibitor-induced thyroiditis is associated with better overall survival in cancer patients. Thyroid 30, 177\u2013184 (2020).","journal-title":"Thyroid"},{"key":"2521_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23661-4","volume":"12","author":"Z Khan","year":"2021","unstructured":"Khan, Z. et al. Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade. Nat. Commun. 12, 3355 (2021).","journal-title":"Nat. Commun."},{"key":"2521_CR28","doi-asserted-by":"publisher","first-page":"102134","DOI":"10.1016\/j.ctrv.2020.102134","volume":"92","author":"S Hussaini","year":"2021","unstructured":"Hussaini, S. et al. Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors\u2014a systematic review and meta-analysis. Cancer Treat. Rev. 92, 102134 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"2521_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006643","volume":"13","author":"S Kasela","year":"2017","unstructured":"Kasela, S. et al. Pathogenic implications for autoimmune mechanisms derived by comparative eQTL analysis of CD4+ versus CD8+ T cells. PLoS Genet. 13, e1006643 (2017).","journal-title":"PLoS Genet."},{"key":"2521_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"2521_CR31","doi-asserted-by":"publisher","first-page":"654569","DOI":"10.3389\/fendo.2021.654569","volume":"12","author":"A L\u00f3pez-M\u00e1rquez","year":"2021","unstructured":"L\u00f3pez-M\u00e1rquez, A., Carrasco-L\u00f3pez, C., Fern\u00e1ndez-M\u00e9ndez, C. & Santisteban, P. Unraveling the complex interplay between transcription factors and signaling molecules in thyroid differentiation and function, from embryos to adults. Front. Endocrinol. 12, 654569 (2021).","journal-title":"Front. Endocrinol."},{"key":"2521_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17718-z","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou, W. et al. GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. Nat. Commun. 11, 3981 (2020).","journal-title":"Nat. Commun."},{"key":"2521_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44701-9","volume":"15","author":"RBTM Sterenborg","year":"2024","unstructured":"Sterenborg, R. B. T. M. et al. Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications. Nat. Commun. 15, 888 (2024).","journal-title":"Nat. Commun."},{"key":"2521_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad115","volume":"39","author":"M Pirinen","year":"2023","unstructured":"Pirinen, M. linemodels: clustering effects based on linear relationships. Bioinformatics 39, btad115 (2023).","journal-title":"Bioinformatics"},{"key":"2521_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20150888","volume":"213","author":"AY Chan","year":"2016","unstructured":"Chan, A. Y. et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J. Exp. Med. 213, 155\u2013165 (2016).","journal-title":"J. Exp. Med."},{"key":"2521_CR36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.immuni.2007.11.013","volume":"27","author":"OM Siggs","year":"2007","unstructured":"Siggs, O. M. et al. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27, 912\u2013926 (2007).","journal-title":"Immunity"},{"key":"2521_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi, N. et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426, 454\u2013460 (2003).","journal-title":"Nature"},{"key":"2521_CR38","doi-asserted-by":"publisher","first-page":"18517","DOI":"10.1073\/pnas.1904271116","volume":"116","author":"JF Ashouri","year":"2019","unstructured":"Ashouri, J. F. et al. Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis. Proc. Natl Acad. Sci. USA 116, 18517\u201318527 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2521_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri2336","volume":"8","author":"A Liston","year":"2008","unstructured":"Liston, A., Enders, A. & Siggs, O. M. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Nat. Rev. Immunol. 8, 545\u2013558 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"2521_CR40","unstructured":"International Classification of Diseases Eighth Revision (WHO, 1965)."},{"key":"2521_CR41","unstructured":"Classificatio Morborum et Causarum Mortis: Tauti- ja kuolinsyyluokitus \/ Klassifikation av sjukdomar och d\u00f6dsorsaker [Classification of Diseases and Causes of Death] (L\u00e4\u00e4kint\u00f6hallitus (National Board of Health), 1969)."},{"key":"2521_CR42","unstructured":"International Classification of Diseases Ninth Revision (WHO, 1977)."},{"key":"2521_CR43","unstructured":"Tautiluokitus 1987, Osa 1: Systemaattinen osa \/ Klassifikation av sjukdomar 1987, Del 1: Systematisk del [Classification of Diseases 1987, Part 1: Systematic Part] (L\u00e4\u00e4kint\u00f6hallitus ja Sairaalaliitto (National Board of Health and Hospital League), 1986)."},{"key":"2521_CR44","unstructured":"International Statistical Classification of Diseases and Related Health Problems Tenth Revision (WHO, 1992)."},{"key":"2521_CR45","unstructured":"Terveyden ja hyvinvoinnin laitos (National Institute for Health and Welfare) Tautiluokitus ICD-10 \/ Klassifikation av sjukdomar ICD-10 [Classification of Diseases ICD-10] 3rd edn (StMichel Print, 2011)."},{"key":"2521_CR46","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/s41588-025-02335-7","volume":"57","author":"KJ Karczewski","year":"2025","unstructured":"Karczewski, K. J. et al. Pan-UK Biobank association analyses enhance discovery and resolution of ancestry-enriched effects. Nat. Genet. 57, 2408\u20132417 (2025).","journal-title":"Nat. Genet."},{"key":"2521_CR47","doi-asserted-by":"publisher","first-page":"100210","DOI":"10.1016\/j.xgen.2022.100210","volume":"2","author":"M Kanai","year":"2022","unstructured":"Kanai, M. et al. Meta-analysis fine-mapping is often miscalibrated at single-variant resolution. Cell Genom. 2, 100210 (2022).","journal-title":"Cell Genom."},{"key":"2521_CR48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41588-022-01036-9","volume":"54","author":"O Weissbrod","year":"2022","unstructured":"Weissbrod, O. et al. Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores. Nat. Genet. 54, 450\u2013458 (2022).","journal-title":"Nat. Genet."},{"key":"2521_CR49","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ajhg.2018.04.001","volume":"102","author":"LG Fritsche","year":"2018","unstructured":"Fritsche, L. G. et al. Association of polygenic risk scores for multiple cancers in a phenome-wide study: results from the Michigan Genomics Initiative. Am. J. Hum. Genet. 102, 1048\u20131061 (2018).","journal-title":"Am. J. Hum. Genet."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02521-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:01:46Z","timestamp":1773424906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02521-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1038\/s41588-026-02521-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4626646\/v1","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"23 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.J.X. is co-founder of Convergence Bio, Board Director at MoonLake Immunotherapeutics, consultant to Nestl\u00e9 and a member of Magnet Biomedicine scientific advisory board. M.J.D. is a founder of Maze Therapeutics. M.I.M. and C.A. are employees of Genentech and holders of Roche stock. Z.K. is a former employee of Genentech and holds Roche stock. K.J.K. is on the Nurture Genomics Scientific Advisory Board. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}